Artificial Tears Market Report 2026

The artificial tears market size has grown strongly in recent years. It will grow from $3.74 billion in 2025 to $3.97 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increasing incidence of dry eye syndrome, rising use of contact lenses, growing awareness about eye care, development of multi-purpose eye drops, presence of major market players.

The artificial tears market size is expected to see strong growth in the next few years. It will grow to $5.07 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to innovation in preservative-free and high molecular weight formulations, growth of e-commerce and online pharmacy channels, increasing geriatric population, technological advancements in drug delivery, expansion in emerging markets. Major trends in the forecast period include growth in prescription and over-the-counter eye drops, rising prevalence of dry eye syndrome, increasing awareness of eye health and preventive care, development of preservative-free formulations, expansion of online pharmacy and e-commerce channels.

The rising prevalence of dry eye disease is expected to drive the growth of the artificial tear market in the coming years. Dry eye disease is a condition in which the eyes either do not produce sufficient tears or the tears are of poor quality, resulting in irritation and discomfort. Artificial tears help supplement natural tear production, providing lubrication and relief for affected eyes. For instance, in February 2024, according to Eyes On Eyecare, a US-based digital media and education company, the clinical focus on dry eye is projected to increase by 13.89%, rising from 37.23% in 2023 to 42.4% in 2024. Therefore, the rising prevalence of dry eye disease is driving growth in the artificial tear market.

Major companies in the artificial tear market are focusing on developing advanced preservative-free formulations to improve ocular comfort, reduce irritation, and enhance treatment adherence for patients with dry eye disease. Preservative-free eye drops are designed to minimize ocular surface toxicity and allow safer long-term use. For instance, in February 2025, Alcon Inc., a Switzerland-based eye care company, launched Systane Pro PF, aimed at relieving dry eye symptoms and improving overall ocular health. The product provides enhanced lubrication and relief, catering to patients with sensitive eyes and chronic dry eye conditions. This launch highlights the increasing emphasis on patient-centric, safer, and more effective therapies in the artificial tears market.

In July 2023, Bausch + Lomb, a Canada-based eye health products company, acquired the Blink product line from Johnson & Johnson for $106.5 million. Through this acquisition, Bausch + Lomb aims to strengthen its portfolio in the over-the-counter (OTC) eye care sector, providing greater consumer convenience and a wider range of eye care solutions. Blink is a US-based pharmaceutical company specializing in lubricating eye drops.

Major companies operating in the artificial tears market are Pfizer Inc, Johnson & Johnson, AbbVie Inc, Novartis AG, Abbott Laboratories, Otsuka Pharmaceutical Co Ltd, Alcon, Bausch Health Companies Inc, Sun Pharmaceutical Industries Ltd, Dr Reddys Laboratories Ltd, Santen Pharmaceutical Co Ltd, Lupin Limited, Rohto Pharmaceutical Co Ltd, Prestige Consumer Healthcare Inc, Thea Pharma Inc, Sentiss Pharma Pvt Ltd, VISUfarma BV, Similasan Corporation, Eyevance Pharmaceuticals LLC, Nicox SA, I MED Pharma Inc, Velocity Pharma LLC.

North America was the largest region in the artificial tears market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial tears market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial tears market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the artificial tears market by increasing the cost of imported raw materials and excipients used in eye drop formulations, thereby raising production costs for manufacturers. The segments most affected include high-end preservative-free and sodium hyaluronate-based tears, with Asia-Pacific and North America being the most impacted regions due to their reliance on global supply chains. While tariffs have created cost pressures, they have also encouraged local manufacturing and sourcing, fostering innovation and efficiency in production processes.

The artificial tears market research report is one of a series of new reports that provides artificial tears market statistics, including artificial tears industry global market size, regional shares, competitors with a artificial tears market share, detailed artificial tears market segments, market trends and opportunities, and any further data you may need to thrive in the artificial tears industry. This artificial tears market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial tears are eye drops, gels, or ointments used to alleviate dryness and irritation of the ocular surface. They are commonly employed to treat dry eye syndrome, a condition resulting from decreased tear production or increased tear evaporation.

The main types of artificial tears include glycerin tears, cellulose tears, oil-based emulsion tears, polyethylene glycol-based tears, sodium hyaluronate-based tears, and propylene glycol-based tears. Glycerin is an ingredient in some artificial tears that helps relieve dry and irritated eyes. These products are available in various forms, including suspensions, solutions, ointments, emulsions, gels, and sprays. They are indicated for conditions such as dry eye syndrome, allergies, infections, UV and blue light protection, contact lens moisture retention, and others. Artificial tears are distributed through multiple channels, including retail pharmacies, hospital pharmacies, online pharmacies, and ophthalmic stores.

The artificial tears market consists of sales of blink tears, soothe XP, genteal tears, and visine tears. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.